Direct comparison of different therapeutic cell types susceptibility to inflammatory cytokines associated with COVID-19 acute lung injury.

Ramana VakaSaad KhanBin YeYousef RishaSandrine ParentDavid CourtmanDuncan J StewartDarryl R Davis

Published in: Stem cell research & therapy (2022)

The paracrine production and viability of the three leading cell products under clinical evaluation for the treatment of severe COVID-19 ARDS are not altered by inflammatory mediators implicated in disease progression.

Keyphrases

clinical evaluation
coronavirus disease
sars cov
single cell
cell therapy
acute respiratory distress syndrome
lps induced
intensive care unit